Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIb study of Aerovant (pitrakinra) to investigate treatment-sparing effects in moderate to severe asthma
2007-006545-41Phase 2Completed
- Sponsor
- Aerovance
- Start
- Dec 2008
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2 trial of pitrakinra in asthma and severe asthma, sponsored by Aerovance. Primary endpoint: Exacerbation incidence. Started Dec 2008; status: completed.
02
Drugs
pitrakinra
03
Conditions
asthmasevere asthma
Beyond the preview
Go deeper on 2007-006545-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-006545-41.